Company Valuation: Shenyang Xingqi Pharmaceutical Co.,Ltd.

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 11,263 11,076 22,715 13,305 - -
Change - -1.66% 105.08% -41.43% - -
Enterprise Value (EV) 11,263 11,076 22,715 13,305 13,305 13,305
Change - -1.66% 105.08% -41.43% 0% 0%
P/E ratio 57.5x 51.9x 94.5x 29.7x 19.9x 17.3x
PBR - - 13.4x 6.22x 4.74x 3.72x
PEG - 41.19x 7.8x 0.3x 0.4x 1.2x
Capitalization / Revenue - - 15.5x 6.28x 4.96x 4.32x
EV / Revenue - - 0x 6.28x 4.96x 4.32x
EV / EBITDA - - 0x 13.6x 10.1x 8.28x
EV / EBIT - - 0x 26.5x 17.9x 15.5x
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 1.214 1.23 1.379 2.571 3.836 4.407
Distribution rate - - - - - -
Net sales 1 - - 1,468 2,117 2,680 3,082
EBITDA 1 - - 361.4 976 1,312 1,606
EBIT 1 - - 276.5 503 744 857
Net income 1 194.7 211.7 240 449 669 768
Net Debt - - - - - -
Reference price 2 69.80 63.82 130.23 76.28 76.28 76.28
Nbr of stocks (in thousands) 161,372 173,568 174,425 174,425 - -
Announcement Date 22-04-19 23-04-19 24-04-18 - - -
1CNY in Million2CNY
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio EV / Sales EV / EBITDA Yield (Y) Capi. ($)
29.66x - - - 1.87B
24.7x3.77x13.33x+1.36%81.29B
24.95x2.8x11.87x+1.81%12.01B
60.04x4.34x51.17x+0.35%6.75B
109.64x14.55x79.58x-.--%5.83B
34.62x6.21x19.28x+0.65%2.36B
11.38x - - +17.58%1.93B
107.17x - - - 1.71B
17.45x - - +0.74%1.34B
Average 46.63x 6.34x 35.05x +3.21% 12.79B
Weighted average by Cap. 32.31x 4.33x 19.23x +1.53%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 300573 Stock
  4. Valuation Shenyang Xingqi Pharmaceutical Co.,Ltd.
-40% off all our subscriptions*.
Last hours!
Days
Hours
Minutes
Seconds
Subscribe now
-40% off all our subscriptions*.
Last hours!
Days
Hours
Minutes
Seconds
Subscribe now